Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy

M. Tsai, Y. Shiau, C. Kao, Y. Shen, C. Lin, C. Lee

Research output: Contribution to journalJournal Article peer-review

58 Scopus citations

Abstract

Purpose: The aim of this study was to evaluate the effectiveness of positron emission tomography (PET) using 18-fluoro-2-deoxyglucose (FDG) to detect recurrent nasopharyngeal carcinomas (NPC) when magnetic resonance imaging (MRI) findings are indeterminate. Patients and methods: After radiotherapy, 28 NPC patients with indeterminate MRI findings were included. MRI, FDG-PET, and biopsy were performed at least 4 months after radiotherapy and within 1 week. The final results were based on histopathologic findings and a clinical follow-up of at least 6 months. Results: For detecting recurrent NPC in indeterminate MRI findings, the sensitivity, specificity and accuracy of FDG-PET were 100.0%, 92.9% and 96.4%, respectively. Conclusions: Based on these results, we can recommend FDG-PET for detecting recurrent NPC when MRI findings are indeterminate.

Original languageEnglish
Pages (from-to)279-282
Number of pages4
JournalJournal of Cancer Research and Clinical Oncology
Volume128
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Keywords

  • 18-Fluoro-2-deoxyglucose
  • Nasopharyngeal carcinomas
  • Positron emission tomography

Fingerprint

Dive into the research topics of 'Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy'. Together they form a unique fingerprint.

Cite this